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Highlights 
 This study investigated the psychological health & well-being of women 
with DM. 
 A total of 640 women (320 with DM & 320 without DM) were interviewed. 
 Women with DM had higher depressive & anxiety symptoms compared to 
women without DM. 
 Women without DM had higher scores for the sexual domain compared to 
women with DM. 
 Diabetes has negative impact on women’s psychological and sexual 
health. 
 
 
Abstract 
Anxiety and depression are more common among females and those experiencing 
diabetes and menopause. Menopausal symptoms experienced by women can vary 
tremendously from population to population; therefore, there is a need to investigate 
these symptoms and associated risk factors in different communities. This study 
investigated the differences in psychological health and menopause-specific quality of 
life (MENQOL) between women with and without diabetes type 2 (T2DM) in Malaysia. 
Women with T2DM (n=320) were matched by age range to controls without T2DM 
(n=320). Data were collected from March 2012 to January 2013. Delusions Symptoms 
States Inventory (DSSI) instrument was used to identify symptoms of depression and 
anxiety. Women with diabetes had higher depressive (11.8% versus 8.4%) and anxiety 
(8.4% versus 6.6%) symptoms compared to women without diabetes. In both groups, 
the most common menopausal symptom was aches (muscles and joints). Women 
without diabetes had significantly higher scores for the sexual domain compared to 
women with diabetes (4.20 versus 3.21, p = 0.001). The odds that a postmenopausal 
woman with diabetes was depressed or anxious on the DSSI scale increased 
significantly when the MENQOL score on the physical, vasomotor, and psychosocial 
domains increased by one unit. Both diabetes and psychological problems have 
negative impact on MENQOL. Our findings support the view of screening 
postmenopausal women with diabetes for depressive and anxiety, to improve overall 
quality of life. 
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1. Introduction 
The world prevalence of diabetes is increasing rapidly; diabetes affected 382 million 
people worldwide in 2013 and the number is projected to rise to 592 million by 2035 
(IDF, 2013). The prevalence is expected to shift to the South East Asia Region by 2025, 
with an estimated prevalence of 13.5% and affecting 145 million people (IDF, 2013; IDF, 
2003). In Malaysia, a middle-income, developing country located in the South East Asia 
Region, the prevalence of diabetes has doubled over the past decade (Hasan et al., 
2013; Zanariah et al., 2010). The National Health and Morbidity Survey I (NHMS-I) 
conducted in 1986, reported a 6.3% prevalence of diabetes among adults aged ≥35 
years; however, the prevalence rose to 8.3% in 1996 and 15.2% in 2011 (Institute for 
Public Health, 2011; Zanariah et al., 2010). WHO estimates a total of 2.48 million 
people with diabetes in Malaysia by 2030 (Zanariah et al., 2010). In other developing 
countries such as China, Brazi l and Egypt, diabetes is more prevalent among women, 
regardless of age (Hu et al., 2001; Wild et al., 2004). The prevalence of diabetes 
worldwide is similar among men and women although it is more prevalent in women 
after the age of 65 years (Wild et al., 2004). 
 
Diabetes mellitus is one of the chronic, inherited or acquired diseases where patients 
experience a number of co-morbidities including physical and psychological problems 
(aHasan et al., 2013). Depression and anxiety are two common, co-morbid, modifiable 
psychological conditions associated with diabetes (bHasan et al., 2013; Smith et al., 
2013), and recent meta-analyses have found significant and positive associations for  
diabetes with both depression (bHasan et al., 2013), and anxiety (Smith et al., 2013) 
although, Brown et al. found no association (Brown et al., 2006). Co-morbid conditions 
of diabetes with depression and/or anxiety intensify the burden of diabetes symptoms 
(Katon, 1982; Konen et al., 1996), increase complications (Kaholokula et al., 2003), 
increase glycaemic levels (Gary et al., 2000), increase non adherence to medications 
(Lin et al., 2004), and reduce quality of life (Lloyd et al., 2000). Despite the high 
prevalence of diabetes in the general population in Malaysia (Institute for Public Health, 
2011; Zanariah et al., 2010), only a few cohort or case-control studies are available on 
this topic. These studies support the hypotheses that people with diabetes are more 
likely to have depression or anxiety symptoms than people who do not have diabetes 
(Kaur et al., 2013; Subramaniam et al., 2009). Some authors have also suggested that 
depression and anxiety symptoms are significantly higher in postmenopausal women 
compared to premenopausal women (Saqsoz et al., 2001). 
 
Type 2 diabetes mellitus is one of the most common chronic diseases in women after 
menopause (Monterrosa-Castro et al., 2013). However, whether menopausal status 
independently influences or increases diabetes risk remains controversial (Kim, 2012; 
Monterrosa-Castro et al., 2013; Szmuilowicz et al., 2009). There is a higher prevalence 
of diabetes among women with a history of menstrual irregularity (Roumain et al., 
1998), particularly in those with long and highly irregular menstrual cycles (Solomon et 
al., 2001). The increase in abdominal fat caused by depletion of ovarian function (Meyer 
et al., 2011), may cause disturbances in insulin sensitivity and glucose metabolism in 
postmenopausal women (Szmuilowicz et al., 2009). The changes in hormonal levels 
during the menopausal transition and after menopause can trigger fluctuations in blood 
glucose levels (Otsuki et al., 2007). The changes in hormonal levels may also result in 
weight gain (Simkin-Silverman et al., 2000), sleep (Australian Menopause Society, 
2013), and sexual problems (Dennerstein et al., 2003). 
 
Women can experience a number of menopausal symptoms as part of a normal 
physiological process that often occurs in women at an average age of 50 years (Burger 
et al., 2002). These symptoms are often attributable to reduced hormone levels and 
include vasomotor, psychological, musculoskeletal or physical and urogenital or sexual 
symptoms (Ogbera et al., 2011). These symptoms can affect the quality of life as 
measured by Menopause Specific Quality of Life (MENQOL) in postmenopausal women 
(Williams et al., 2009). Women with diabetes generally appeared to have worse quality 
of life and mental well-being compared to men with diabetes; explicitly, more diabetes-
related worries and less ability to cope (Unden et al., 2008). This suggests that diabetes 
combined with menopausal symptoms may significantly reduce quality of life. 
 
Anxiety and depression are more common among females and those experiencing 
diabetes and menopause; hence women are the target population in our study (Collins 
et al., 2009; Grigsby et al., 2002; Khuwaja & Kadir, 2010). Menopausal symptoms 
experienced by women can vary tremendously from individual to individual, and 
population to population (Gold et al., 2000; World Health Organization, 1990; World 
Health Organization, 1996); therefore, there is a need to investigate these symptoms 
and associated risk factors in different communities. The primary objective of this study 
was to determine the pattern of menopausal symptomatology in Malaysian women with 
and without type 2 diabetes. The specific aims of this study include the following: to  
determine the association between symptoms of depression and anxiety and type 2 
diabetes, and MENQOL domains and type 2 diabetes using case-control data; and to 
compare the symptomatology of menopause in postmenopausal women with and 
without type 2 diabetes. 
 
2. Methods 
2.1. Study design and population  
This study involved women with diabetes matched to women without type 2 diabetes in 
the same age range. A frequency matching technique was used to match participants 
on cell instead of individual basis. The frequency matching was conducted using two 
conditions: presence or absence of diabetes and aged 35 years or more. The frequency 
matching was completed in two steps. In the first step, only women aged 35 and older 
who attended outpatient clinics for the management of T2DM and who had a known 
diagnosis of T2DM were selected (cases). In the second step, cases were matched with 
controls; these were women aged 35 years and older, with no known diagnosis of 
T2DM. The control participants were healthy friends or unrelated family members (no 
blood relation) of women with type 2 diabetes. 
 
Three Medication Therapy Adherence Clinics (MTACs), two hospital-based (Hospital 
Putrajaya and Hospital Tuanku Jaa’far Seremban) and one Health Clinic (Health Clinic, 
Seremban) in West Malaysia were selected as primary sampling sites. Non probability-
based design was used to select the sampling sites. Recruitment was initially started in 
Hospital Putrajaya where the majority of the patients were of Malay origin. Therefore, to 
select a sample that included all three ethnic groups, sampling was extended to the 
Seremban region to include patients of Chinese and Indian ethnicity. Data were 
collected from March 2012 to January 2013. 
 
Every second woman with diabetes on the respective patients’ lists at the clinic sites 
was systematically invited to participate; verbal or written consent was obtained from 
participants who met the inclusion criteria. Out of 415 women with diabetes invited to 
participate in the study, 320 (77%) accepted and participated. Out of 390 women 
without diabetes who were invited to participate, 320 (82%) accepted and participated. 
Face-to-face interviews were conducted at the outpatient clinics, using study 
questionnaires. 
 
2.2. Assessment of Type 2 diabetes 
Data on type 2 diabetes were collected through a self-administered questionnaire, 
where women were asked “Have you EVER been told by a doctor that you have 
diabetes (high blood sugars)?” with response options “yes” or “no.” Participants were 
categorized as having type 2 diabetes if they had been told by a physician they had 
diabetes. Information was further confirmed by accessing patients’ medical records. The 
presence of type 2 diabetes is identified in the hospital according to two criteria: A 
fasting plasma glucose (FPG) greater than or equal to 7.0 mmol/l, and random plasma 
glucose (RPG) greater than or equal to 11.1 mmol/l. Participants were not recruited if 
data on their blood glucose levels were missing, and women diagnosed with type 1 
diabetes were excluded. The 320 women with diabetes were categorized based on the 
duration of type 2 diabetes: 0–5 years, 6–10 years, and >10 years. 
 
2.3. Delusion Symptoms States Inventory (DSSI) – study instrument 
The information about the presence of depression and anxiety symptoms was 
measured by Delusion Symptoms States Inventory: State o f Anxiety and Depression 
(DSSI/sAD). The DSSI, a 14-item self-administered questionnaire which assesses the 
mood states of anxiety and depression has been validated against clinical samples with 
diagnosed mental illness (Bedford & Folds, 1977; Foulds & Bedford; Morey, 1985). The 
DSSI correlates well, and shares items with, other established symptoms scales such 
as the Edinburgh Postnatal Depression Scale (EPDS) and the Hospital 
Anxiety/Depression Scale (HADS) (Bedford & Deary, 1999; Najman et al., 2000). Hasan 
et al (2015) tested the instrument against CES-D, SF-36 and DSM-IV based diagnoses 
in people with diabetes and found strong relationships with equivalent SF-36 & CES-D 
scales and high specificity with low sensitivity, compared with the DSM IV (Hasan et al., 
2015). The DSSI contains 14 symptoms; 7 for depression and 7 for anxiety. Participants 
in this study were classified as anxious or depressed when they scored 4 or more.  
2.4. Menopausal status 
Menopausal status was identified as pre-menopausal (no irregular periods in the 
previous 12 months, peri-menopausal (irregular periods less than 12 months), or post-
menopausal (cessation of menses for 12 months or longer; included both natural as well 
as surgical). There were very few women with peri-menopausal status; therefore we did 
not include them in the analysis and focused on pre and post-menopausal women only. 
 
2.5. Measurement of menopause specific quality of life (MENQOL) 
Since MENQOL is validated only in the postmenopausal population, MENQOL 
assessment was restricted to postmenopausal women only. The MENQOL is a 
validated instrument used to measure quality of life and is able to capture not only the 
existence of frequent menopausal symptoms, but also the extent to which the 
symptom(s) is/are bothersome (Hilditch et al., 1996; Van Dole et al., 2012). MENQOL 
was developed using data from postmenopausal women, aged between 47 to 62 years 
who had not been on hormone replacement therapy Hilditch et al., 1996; Van Dole et 
al., 2012). We used 29 questions in this study (3 questions on vasomotor aspects, 7 
questions on psychosocial aspects, 16 questions on physical aspects and 3 questions 
on sexual aspects).  
 
According to the scoring system of the original version of MENQOL, each question 
should be scored by 8 points using a Likert scale from 2 to 8, or ‘not at all bothered’ to 
‘extremely bothered’. Thus, higher scores represent poorer quality of life. For analyses, 
we scored the items ranging from 1 to 8 in the following manner: (1) The participant 
responded ‘NO’, she did not experience the problem; (2) the participant experienced the 
problem and rated it as ‘0’ on the bothered scale; (3) The participant experienced the 
problem and rated it as ‘1’ on the bothered scale; (4) rated as ‘2’; (5) rated as ‘3’; (6) 
rated as ‘4’; (7) rated as ‘5’; (8) rated as ‘6’. Each domain score ranges from 1 to 8  
Hilditch et al., 1996; Van Dole et al., 2012). The total scores for vasomotor aspects 
ranged from 3 to 24; psychosocial aspects from 7 to 56; physical aspects from 16 to 
128; and sexual aspects from 3 to 24. The total MENQOL score for each participant 
ranged from 29 (the lowest level) to 232 (the highest level) points. The MENQOL 
instrument has been validated for measuring quality of life in postmenopausal women 
with diabetes (cHasan et al., 2013). 
This study was approved by the Ethics Committee at the School of Pharmacy, The 
University of Queensland (Reg. No. 2011/14) and by the International Medical 
University Research and Ethics Committee (Project ID No: B01/09-Res (04) 2012). The 
study was registered with the National Medical Research Registry (NMRR), Mi nistry of 
Health, Malaysia (ID: 12444). 
 
2.6. Statistical analysis 
The data were analyzed using the Statistical Package for Social Sciences (SPSS)® 
version 20 and STATA IC® version 12, with a significance level of ≤ 0.05. Descriptive 
statistics were used to calculate percentages frequencies, means and standard 
deviations. The relationship between variables for categorical data were performed 
using the X2 (Chi-Sq). Fisher’s Exact test was applied in cases where the sample size 
was small and on occasions where we had less than 5 readings per cell for Chi-Square. 
Comparisons between groups with normal distribution were performed using the 
Student’s t-test. To verify the existence of a correlation between the mean scores or 
other values of instruments, Pearson’s correlation test was used. Logistic regression 
was used to investigate the relationship between: psychological conditions (depression 
and anxiety symptoms) and diabetes, and menopausal symptoms and diabetes. The 
potential confounders and risk factors were identified on the basis of their association 
with outcomes and on the basis of a priori knowledge (bHasan et al., 2013; Kaur et al., 
2013; Smith et al., 2013). Multiple logistic regressions were then used to assess the 
relationship, after adjustment for other potential confounding variables. We present a 
series of models that were adjusted for these potential confounders so that readers can 
see the effect of factors that we consider might confound this association.  The overall 
extent to which a given model fits the data was measured by a Goodness-of-Fit test. 
Maximum Likelihood method was applied because it minimises bias and maximises 
precision of estimates. We did not include any interaction terms in the model. 
 
The final multivariate model included seven covariates, selected using priori knowledge. 
Height (m) and weight (kg) measurements were obtained from participants’ medical 
records and used to calculate body mass index (BMI) (kg/m2). BMI 30 or greater was 
used as the cut-off point to categorize participants as obese and non-obese. The 
information on comorbidities or medical conditions other than type 2 diabetes was 
collected from medical records. Socio-demographic information were collected from 
patients and included age, ethnicity (Malay, Chinese, Indians and others), education (no 
formal education, primary education, secondary education and graduation or post-
graduation), monthly income in Ringgit Malaysia (1 RM = 3.2 $ US) . In this study, the 
woman was asked about her current marital status, that is, whether she was single, 
married, divorced, or widowed. 
 
3. Results 
A total of 640 women (320 people with diabetes and 320 people without diabetes) were 
interviewed, and the socio-demographic characteristics of those with diabetes and those 
without diabetes are summarised in Table 1. The median age at diagnosis of diabetes 
was 50 years (Range: 27 – 70); patients with diabetes were slightly older than those 
without diabetes, with a mean difference in age of 9.3 ± 1.05. In the diabetes group, 
most of the participants were of Indian origin (37%), no income (54%), and had at least 
one comorbid condition. The diabetes group had lower education and income levels 
than the group without diabetes (p<0.05). None of the participants smoked and only a 
few (<5) were consuming alcohol at the time of study. 
 
Of the total number of participants, 378 women (with diabetes = 258, control = 120) had 
attained menopausal status, while 262 women (with diabetes = 62, control = 200) had 
not attained menopausal status. Both women with and without diabetes experienced 
their first period around the same age (mean age: 13.25 versus 13.10, p = 0.680). 
Similarly they attained menopause around the same age (mean age: 49.35 versus 
48.87, p = 0.426). Women with diabetes had a higher number of pregnancies (mean: 
4.15 versus 3.64, p = 0.001), percentage of gestational diabetes and hypertension 
(13.4% versus 8.1%, p = 0.03) and miscarriages (22% versus 15%), compared to 
women without diabetes. 
 
3.1. Anxiety, depression and type 2 diabetes 
Women with diabetes had slightly higher depressive (11.8% versus 8.4%) and anxiety 
symptoms (8.4% versus 6.6%) compared to women without diabetes. Postmenopausal 
women in the diabetes group and premenopausal women in the control group had 
slightly higher proportions of depressive and anxiety symptoms compared to their 
counterparts. 
In the diabetes group, most of the depressed and anxious participants were aged 45 – 
54 years (27.0% and 27.5% respectively), married (49% and 50%), had completed 
secondary education (35% and 30%), and received a monthly income of 7000 Ringgit 
Malaysia or more (24% and 23%). Anxiety was more commonly reported by Chinese 
women (30%), while depression was more frequently found among Indians (19%). In 
the non-diabetes group, most of the depressed and anxious participants were older, of 
Indian origin, had attained only primary education, and belonged to the lower socio-
economic group. Women with 0 to 5 years’ duration of diabetes had the highest 
percentages of depression and anxiety symptoms compared to those with 6 or more 
years of diabetes. 
 
In the multivariate logistic regression model, the association between depressive 
symptoms and diabetes was not statistically significant, both in postmenopausal (OR 
0.39, 95% CI: 0.13 – 1.17) as well as in premenopausal women (OR 0.27, 95% CI: 0.10 
– 1.33), as shown in Table 2. Similarly, in the case of anxiety, we did not find significant 
association between anxiety symptoms and diabetes, both in postmenopausal (OR 
0.46, 95% CI: 0.12 – 1.71) and premenopausal women (OR 0.91, 95% CI: 0.10 – 8.62).  
 
3.2. MENQOL domains and type 2 diabetes 
Since MENQOL is only validated in the postmenopausal population, MENQOL 
assessment was restricted to postmenopausal women only (case = 258, control = 120). 
A comparison of the pattern of occurrence of menopausal symptoms in postmenopausal 
women with and without the diabetes is presented in Table 3. In both groups, the most 
common menopausal symptom was aches of muscles and joints (> 70%) while 
symptoms originating from sexual aspects were the least self-reported. In terms of 
pattern of occurrence of specific menopausal symptoms in postmenopausal women, 
women with diabetes reported significantly higher percentages compared to women 
without diabetes for the following symptoms: nights sweats (32.9% versus 21.7%, p = 
0.025), decrease in physical strength (72.1% versus 56.7%, p = 0.003), decrease in 
stamina (73.3% versus 53.3%, p = 0.001), lack of energy (73.6% versus 54.2%, p = 
0.001), and frequent urination (51.9% versus 27.5%, p = 0.001).  
 
Women with diabetes had insignificantly higher scores for vasomotor (6.17 versus 5.75, 
p = 0.357) and physical (37.01 versus 36.75, p = 0.884) domains compared to women 
without diabetes. However in terms of total MENQOL score, women without diabetes 
had an insignificantly higher score (59.85 versus 58.36, p = 0.566). Interestingly women 
without diabetes also had significantly higher score for the sexual domain compared to 
women with diabetes (4.20 versus 3.21, p = 0.001).  
 
The odds that a postmenopausal woman did not have diabetes, significantly increased 
when the MENQOL score on the sexual domain decreased by one unit (OR 0.69, 95% 
CI: 0.57–0.84). The results for other domains were statistically insignificant. Table 4 
shows the results of the logistic regression analysis examining the relationship between 
the presence or absence of diabetes and each of the four MENQOL domains. 
 
3.3. Depression, anxiety and MENQOL domains  
The odds that a postmenopausal woman with diabetes was depressed on the DSSI 
scale increased 1.13 times when the MENQOL score on the vasomotor domain 
increased by one unit (95% CI: 1.04–1.22), the odds ratio increased 1.14 times when 
the MENQOL score on the psychosocial domain increased by one unit (95% CI: 1.07–
1.21), and the odds ratio increased 1.08 times when the MENQOL score on the physical 
domain increased by one unit (95% CI: 1.04–1.11). Similar results were obtained for 
anxiety symptoms and MENQOL domains. Similarly, the odds that a postmenopausal 
woman without diabetes was depressed or anxious on the DSSI scale increased 
significantly when the MENQOL score on the physical, vasomotor, and psychosocial 
domains increased by one unit. Table 5 shows the results of the logistic regression 
analysis examining the relationship between symptoms of depressive and anxiety and 
each of the four MENQOL domains. 
 
4. Discussion 
This study investigated the psychological health and menopause-specific quality of life 
among pre and postmenopausal women with and without diabetes in Malaysia. In this 
study, most of the patients with diabetes were of Indian origin (36.6%), followed by 
Chinese (30.9%) and Malay (30.6%); these demographics are similar to those of NHMS 
III (Zanariah et al., 2010). Women with diabetes were slightly older than women who did 
not have diabetes, suggesting that the age range differs between the two groups. The 
sharpest increase in the prevalence of diabetes occurred after the age of 55 years.  
Women in the 55 to 64 year age group had the highest proportion of diabetes. In our 
study, about 40% of those with type 2 diabetes had experienced menopause compared 
to only 18% of those without diabetes, suggesting that an earlier onset of diabetes 
results in an earlier age of menopause. This is consistent with reports that revealed an 
early menopausal age for women with diabetes compared to women without diabetes 
(Malacara et al., 1997; Monterrosa-Castro et al., 2013).  
 
As described earlier, women experience a variety of symptoms during or after 
menopause (Ogbera et al., 2011). Consistent with previous reports (Australian 
Menopause Society, 2013; Ogbera et al., 2011), the most common complaint reported 
by participants in both groups was aches in muscles and joints. Our findings are also 
similar to those of Ogbera et al., who found that half the women in both groups reported 
poor memory (Ogbera et al., 2011). In terms of MENQOL domains, symptoms 
originating from the sexual aspects were the least self-reported and the least reported 
symptom was that of facial hair, which occurred in 2.4% of the participants. This is in 
agreement with a study among menopausal Arabic women in Sydney (Lu et al., 2007), 
where the presence of facial hair was the least reported menopausal symptom.  
 
Of the physical, psychosocial and sexual symptoms, our findings show that night 
sweats, decreased physical strength, decreased stamina, lack of energy, and frequent 
urination were the predominant menopausal symptoms reported by our participants  with 
diabetes. The MENQOL instrument used for screening menopausal symptoms 
contained some symptoms that could be confounded with symptoms of diabetes or poor 
controlled diabetes (Hilditch et al., 1996; Van Dole et al., 2012). However, we 
demonstrated the validity of MENQOL domains in a sample of women with diabetes in a 
previous study and concluded that MENQOL can be administered to a population with 
diabetes (cHasan et al., 2013). 
 
Although women with diabetes reported higher percentages of depression (11.8% 
versus 8.4%) and anxiety symptoms (8.4% versus 6.6%) compared to women without 
diabetes, the differences were statistically insignificant. Similarly, anxiety (31.8% versus 
33.3%) and depression symptoms (20.9% versus 20.8%) as measured by the 
psychosocial domain of MENQOL were also similar for both groups, suggesting that 
attainment of menopausal status did not increase or decrease the psychological burden 
in participating women. A recent study in Malaysia (2013) found a relatively higher 
prevalence of depression and anxiety symptoms among people with diabetes (Kaur et 
al., 2013). This may be a result of differences in the screening instrument, the age 
groups (less than 35 and more than 75 years), and the inclusion of male participants. 
Consistent with the findings of previous studies, we found that depression was more 
prevalent among women of Indian ethnicity (19%), while anxiety was more prevalent 
among the Chinese ethnicity (30%) (Dunlop et al., 2003; Fisher et al., 2004). Ben-
Haroush et al., hypothesized that minority groups, are more likely to experience 
socioeconomic constraints, poor education and perceived discrimination that may result 
in higher prevalence of psychological and chronic conditions (Ben-Haroush et al., 2004); 
this applies particularly to Indians in our study,.  
 
Women with duration of 0 to 5 years of diabetes had the highest percentages of 
depression and anxiety symptoms compared to those with 6 or more years of diabetes. 
Our findings are in agreement with previous studies conducted in Malaysia (2013) and 
Bahrain (2008) (Almawi et al., 2008; Kaur et al., 2013). This may be attributed to 
inadequate or inefficient coping skills for managing diabetes shortly after diagnosis.  
 
Co-morbid conditions of diabetes and anxiety disorders are linked to increased diabetes 
burden (Andrews et al., 1998), increased complications (Jonas et al., 1997), poor 
glycaemic control (Anderson et al., 2002), and reduced quality of life (Mendlowicz & 
Stein, 2001). However, there has been little focus on the association of diabetes with 
anxiety. A recent meta-analysis found significant and positive associations for diabetes 
with both anxiety disorders and elevated anxiety symptoms (Smith et al., 2013). 
However, a limited number of longitudinal studies from developed countries reported 
inconsistent results about the association between anxiety and diabetes (Smith et al., 
2013). Anxiety is an episodic disorder and participants may have not had anxiety attacks 
during the time of the studies. We also noted significant positive correlation between 
anxiety and depression suggesting that as the depression symptoms increased, anxiety 
symptoms correspondingly increased. It is well established that depression and anxiety 
go hand in hand and they are usually diagnosed together (Center for Disease Control 
and Prevention, 2008). 
 
Regarding depression as a cause of diabetes, previous studies reached different 
conclusions (aHasan et al., 2013); Saydah et al. found no evidence to support an 
etiological relationship between depression and diabetes (Saydah et al., 2003), and a 
retrospective Scandinavian study published in 2004 also reported no overall relationship 
(van den Akker et al., 2004). However, a recent meta-analysis (2013) documented that 
symptoms of depression are associated with diabetes (aHasan et al., 2013).  
 
4.1. Limitations 
There are a number of limitations associated with this study that may affect the 
generalizability of our findings. This study used self-report scales to assess 
menopausal, depressive and anxiety symptoms; although diagnosis of these conditions 
by a trained health care professional according to standard criteria would be preferable, 
this was not possible. Participant recall bias may be a systematic error due to lack of 
completeness of memory of past events or experiences, and may have affected the 
accuracy of self-reported information. Although we applied systematic sampling, 
participants who frequently attended the outpatient clinics were more likely to be 
sampled than those who attended less frequently; we presume that they had better 
overall health status due to their regular attendance. This may have introduced 
selection bias. Finally, the control group is slightly younger than the group of cases and 
there also seem to be differences in ethnicity and income level. These differences in 
cases and controls could well explain differences in depressive and anxiety symptoms. 
 
5. Conclusions 
Despite some limitations this study has both clinical and research implications. From the 
clinical perspective, the results indicate that symptoms of depression and anxiety are 
more prevalent among women with diabetes than women without diabetes. Both 
diabetes and psychological issues have negative impact on MENQOL. Except for some 
aspects, the menopausal symptomatology in Malaysian women with type 2 diabetes is 
comparable to symptomology among women without type 2 diabetes. The finding that 
symptoms of depression and anxiety are more prevalent among women with newly 
diagnosed diabetes warrants clinical attention because they are associated with an 
increased risk of developing major forms of depression and/or anxiety. In order to 
achieve desired therapeutic and non-therapeutic outcomes, healthcare professionals 
should screen postmenopausal women with diabetes for depressive and anxiety 
symptoms.  
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Tables 
Table 1: Socio-demographic characteristics of women, by diabetes and menopausal status 
Variables No type 2 diabetes 
N = 320 
N (%) 
Type 2 Diabetes 
N = 320 
N (%) 
Pre-
menopause 
Post-
menopause 
Total 
N 
Pre-
menopause 
Post-
menopause 
Total 
N 
Age       
35 – 44  91 (90.0) 10 (10.0) 101 32 (91.4) 3 (8.6) 35 
45 – 54  104 (67.0) 51 (33.0) 155 28 (39.4) 43 (60.6) 71 
55 – 64  4 (9.1) 40 (90.9) 44 0 (0.0) 127 (100.0) 127 
> 65 1 (5.0) 19 (95.0) 20 2 (2.3) 84 (97.7) 86 
Marital Status       
Single – Not married 10 (90.9) 1 (9.1) 11 1 (100.0) 0 (0.0) 1 
Married 174 (63.0) 102 (37.0) 276 61 (21.2) 226 (78.8) 287 
Divorced 11 (73.3) 4 (26.7) 15 0 (0.0) 4 (100.0) 4 
Widowed 5 (27.8) 13 (72.2) 18 0 (0.0) 28 (100.0) 28 
Ethnicity       
Malay 49 (73.1) 18 (26.9) 67 23 (23.5) 75 (76.5) 98 
Chinese 95 (59.4) 65 (40.6) 160 15 (15.1) 84 (84.9) 99 
Indian 51 (61.5) 32 (38.5) 83 22 (18.8) 95 (81.2) 117 
Others 5 (50.0) 5 (50.0) 10 2 (33.3) 4 (66.7) 6 
Education level       
No educ. 1 (12.5) 7 (87.5) 8 1 (2.4) 40 (97.6) 41 
Primary educ. 20 (55.6) 16 (44.4) 36 29 (18.2) 130 (81.8) 159 
Secondary educ. 100 (59.5) 68 (40.5) 168 25 (25.0) 75 (75.0) 100 
Bachelors or higher 79 (73.1) 29 (26.9) 108 7 (35.0) 13 (65.0) 20 
Monthly income       
No income 30 (49.2) 31 (50.8) 61 15 (8.6) 159 (91.4) 174 
< 3500 35 (66.0) 18 (34.0) 53 20 (23.8) 64 (76.2) 84 
3500 – 6999  54 (62.8) 32 (37.2) 86 12 (36.4) 21 (63.6) 33 
≥ 7000 81 (67.5) 39 (32.5) 120 15 (51.7) 14 (48.3) 29 
Co morbidities       
No 170 (69.1) 76 (30.9) 246 0 (0.0) 0 (0.0) 0 
Yes 30 (40.5) 44 (59.5) 74 62 (19.4) 258 (80.6) 320 
Obesity       
Non obese 182 (61.1) 116 (38.9) 298 53 (17.9) 243 (82.1) 296 
Obese 18 (81.8) 4 (18.2) 22 8 (34.8) 15 (65.2) 23 
 
 
 
 
Table 2: Unadjusted and adjusted odds ratios (95% CI) of depression and anxiety symptoms according to 
diabetes and menopausal status 
Variables  Postmenopausal women (N = 378) Premenopausal women (N = 252) 
No Diabetes 
 (Referent) 
Diabetes No Diabetes 
 (Referent) 
Diabetes 
Depression symptoms   
Unadjusted  1.0 0.42 (0.21 – 0.83) 1.0 0.71 (0.26 – 1.96) 
Age Adjusted  1.0 0.55 (0.26 – 1.15) 1.0 0.71 (0.26 – 1.98) 
Fully Adjusted  1.0 0.39 (0.13 – 1.17) 1.0 0.27 (0.10 – 1.33) 
Anxiety symptoms   
Unadjusted  1.0 0.47 (0.21 – 1.04) 1.0 0.74 (0.24 – 2.29) 
Age Adjusted  1.0 0.54 (0.23 – 1.25) 1.0 0.75 (0.24 – 2.32) 
Fully Adjusted  1.0 0.46 (0.12 – 1.71) 1.0 0.91 (0.10 – 8.62) 
Note: Full logistic model adjusted for age, ethnicity , marital status, education level, monthly  income, comorbidities, and obesity . 
 
 
 
 
 
 
 
Table 3: Comparison of the pattern of occurrence of menopausal symptoms in post-menopausal women 
with and without the diabetes, given as n (%) 
Domains Total 
N = 378 
No diabetes 
N = 120 
Diabetes 
N = 258 
p-value 
Vasomotor      
1. Hot flushes or flashes 86 42 (35.0) 44 (17.1) 0.001 
2. Night sweats 111 26 (21.7) 85 (32.9) 0.025 
3. Sweating 165 54 (45.0) 111 (43.0) 0.718 
Psychosocial      
4. Being dissatisfied with personal life 26 17 (14.2) 9 (3.5) 0.001 
5. Feeling anxious or nervous 122 40 (33.3) 82 (31.8) 0.764 
6. Experiencing poor memory 199 63 (52.5) 136 (52.7) 0.969 
7. Accomplishing less than I used to 82 37 (30.8) 45 (17.4) 0.003 
8. Feeling depressed, down or blue 79 25 (20.8) 54 (20.9) 0.983 
9. Being impatient with other people 134 60 (50.0) 74 (28.7) 0.001 
10. Feelings of wanting to be alone 70 26 (21.7) 44 (17.1) 0.283 
Physical      
11. Flatulence (wind) of gas pains 149 49 (40.8) 100 (38.8) 0.701 
12. Aches in muscles and joints 278 85 (70.8) 193 (74.8) 0.415 
13. Feeling tired or worn out 254 81 (67.5) 173 (67.1) 0.932 
14. Difficulty sleeping 164 50 (41.7) 114 (44.2) 0.645 
15. Aches in back of head or neck 146 65 (54.2) 81 (31.4) 0.001 
16. Decrease in physical strength 254 68 (56.7) 186 (72.1) 0.003 
17. Decrease in stamina 253 64 (53.3) 189 (73.3) 0.001 
18. Feeling a lack of energy 255 65 (54.2) 190 (73.6) 0.001 
19. Drying skin 167 52 (43.3) 115 (44.6) 0.821 
20.  Weight gain 92 44 (36.7) 48 (18.6) 0.001 
21. Increased facial hair 9 8 (6.7) 1 (0.4) 0.001 
22. Changes in appearance, texture or tone 
skin 
67 40 (33.3) 27 (10.5) 0.001 
23. Feeling bloated 56 32 (26.7) 24 (9.3) 0.001 
24. Low backache 148 43 (35.8) 105 (40.7) 0.367 
25. Frequent urination 167 33 (27.5) 134 (51.9) 0.001 
26. Involuntary urination when laughing or 
coughing 
77 27 (22.5) 50 (19.4) 0.483 
Sexual      
27. Changes in sexual desire 36 27 (22.5) 9 (3.5) 0.001 
28. Vaginal dryness during intercourse 39 29 (24.2) 10 (3.9) 0.001 
29. Avoiding intimacy 26 18 (15.0) 8 (3.1) 0.001 
Note: p-value obtained by Chi-Sq test 
Table 4: Results of logistic regression analyses with diabetes as the dependent variable and the 
MENQOL domains as the independent variables (N = 378) 
Domains No Diabetes 
N = 120 
(Referent) 
Diabetes 
N = 258 
p-value 
Vasomotor    
Mean (SD) 5.75 (0.33) 6.17 (0.27) p = 0.357 
Unadjusted  1.0 1.03 (0.97 – 1.08)  
Age Adjusted  1.0 1.06 (0.99 – 1.12)  
Fully Adjusted  1.0 1.07 (0.97 – 1.18)  
Psychosocial    
Mean (SD) 13.15 (0.66) 11.96 (0.37) p = 0.096 
Unadjusted  1.0 0.97 (0.94 – 1.01)  
Age Adjusted  1.0 0.98 (0.94 – 1.01)  
Fully Adjusted  1.0 0.95 (0.91 – 1.00)  
Physical    
Mean (SD) 36.75 (1.67) 37.01 (0.93) p = 0.884 
Unadjusted  1.0 1.00 (0.99 – 1.02)  
Age Adjusted  1.0 1.00 (0.99 – 1.02)  
Fully Adjusted  1.0 0.99 (0.97 – 1.01)  
Sexual    
Mean (SD) 4.20 (0.20) 3.21 (0.08) p = 0.001 
Unadjusted  1.0 0.68 (0.58 – 0.81)*  
Age Adjusted  1.0 0.68 (0.58 – 0.80)*  
Fully Adjusted  1.0 0.69 (0.57 – 0.84)*  
Total MENQOL score    
Mean (SD) 59.85 (2.48) 58.36 (1.38) p = 0.566 
Unadjusted  1.0 1.00 (0.99 – 1.01)  
Age Adjusted  1.0 0.99 (0.99 – 1.01)  
Fully Adjusted  1.0 0.99 (0.98 – 1.01)  
Note: Means were compared using t test. Full logistic model adjusted for age, ethnicity , marital status, comorbidities, and obesity . 
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Table 5: Results of logistic regression analyses with depression and anxiety symptoms as the 
dependent variables and the MENQOL domains as the independent variables, by diabetes (N = 378) 
Dependent Domains Odds Ratio p-value 95% CI 
Women with diabetes (n = 258)  
Depression a Vasomotor 1.13 0.004 1.04 – 1.22 
 Psychosocial 1.14 0.001 1.07 – 1.21 
 Physical 1.08 0.001 1.04 – 1.11 
Anxiety b Vasomotor 1.18 0.001 1.07 – 1.29 
 Psychosocial 1.14 0.001 1.07 – 1.22 
 Physical 1.09 0.001 1.05 – 1.13 
Women without diabetes (n = 
120) 
 
Depression a Vasomotor 1.22 0.002 1.08 – 1.39 
 Psychosocial 1.19 0.001 1.10 – 1.30 
 Physical 1.06 0.001 1.03 – 1.10 
 Vaginal/Sexual 0.98 0.884 0.78 – 1.24 
Anxiety b Vasomotor 1.23 0.006 1.06 – 1.42 
 Psychosocial 1.21 0.001 1.10 – 1.34 
 Physical 1.06 0.289 1.03 – 1.10 
 Vaginal/Sexual 1.01 0.931 0.79 – 1.29 
a = depression was measured with DSSI: depressed = 1; not depressed = 0; b = anxiety  was measured with DSSI: anx ious = 1; not anx ious 
= 0; Logistic model adjusted for age and marital status 
 
 
